Yousefpour, Parisa
Ni, Kaiyuan
Irvine, Darrell J.
Article History
Accepted: 28 November 2022
First Online: 30 January 2023
Competing interests
: D.J.I. is an inventor on patents related to albumin hitchhiking (discussed under ‘Principles of lymph node targeting’), nanoparticle modification of T cells (discussed under ‘Backpacking’ cells’) and alum-binding cytokines (discussed under ‘Intratumoral delivery of biomaterials for immune cell targeting’). These patents have been licensed to Elicio Therapeutics, Repertoire Immune Medicines and Ankyra Therapeutics, respectively, and D.J.I. holds equity in these companies. The remaining authors declare no competing interests.
Free to read: This content has been made available to all.